As of 2025-07-11, the EV/EBITDA ratio of Pliant Therapeutics Inc (PLRX) is -0.11. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. PLRX's latest enterprise value is 24.29 mil USD. PLRX's TTM EBITDA according to its financial statements is -219.95 mil USD. Dividing these 2 quantities gives us the above PLRX EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | EV/EBITDA |
| 2025-07-10 | -0.11 |
| 2025-07-09 | -0.10 |
| 2025-07-08 | -0.05 |
| 2025-07-07 | -0.05 |
| 2025-07-03 | -0.07 |
| 2025-07-02 | -0.05 |
| 2025-07-01 | -0.05 |
| 2025-06-30 | -0.04 |
| 2025-06-27 | -0.07 |
| 2025-06-26 | -0.08 |
| 2025-06-25 | -0.10 |
| 2025-06-24 | -0.08 |
| 2025-06-23 | -0.07 |
| 2025-06-20 | -0.08 |
| 2025-06-18 | -0.09 |
| 2025-06-17 | -0.09 |
| 2025-06-16 | -0.10 |
| 2025-06-13 | -0.10 |
| 2025-06-12 | -0.13 |
| 2025-06-11 | -0.13 |
| 2025-06-10 | -0.15 |
| 2025-06-09 | -0.17 |
| 2025-06-06 | -0.17 |
| 2025-06-05 | -0.17 |
| 2025-06-04 | -0.18 |
| 2025-06-03 | -0.17 |
| 2025-06-02 | -0.12 |
| 2025-05-30 | -0.10 |
| 2025-05-29 | -0.10 |
| 2025-05-28 | -0.10 |
| 2025-05-27 | -0.08 |
| 2025-05-23 | -0.08 |
| 2025-05-22 | -0.09 |
| 2025-05-21 | -0.09 |
| 2025-05-20 | -0.10 |
| 2025-05-19 | -0.10 |
| 2025-05-16 | -0.10 |
| 2025-05-15 | -0.10 |
| 2025-05-14 | -0.10 |
| 2025-05-13 | -0.10 |
| 2025-05-12 | -0.13 |
| 2025-05-09 | -0.11 |
| 2025-05-08 | -0.13 |
| 2025-05-07 | -0.12 |
| 2025-05-06 | -0.12 |
| 2025-05-05 | -0.16 |
| 2025-05-02 | -0.19 |
| 2025-05-01 | -0.17 |
| 2025-04-30 | -0.16 |
| 2025-04-29 | -0.13 |